Metropolitan Life Insurance Company (MetLife)’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-23,656
| Closed | -$426K | – | 2618 |
|
|
2020
Q2 | $426K | Hold |
23,656
| – | – | 0.01% | 1332 |
|
|
2020
Q1 | $169K | Sell |
23,656
-39
| -0.2% | -$487 | ﹤0.01% | 1688 |
|
|
2019
Q4 | $566K | Hold |
23,695
| – | – | 0.01% | 1248 |
|
|
2019
Q3 | $636K | Buy |
23,695
+2,557
| +12% | +$71.8K | 0.01% | 1141 |
|
|
2019
Q2 | $573K | Hold |
21,138
| – | – | 0.01% | 1227 |
|
|
2019
Q1 | $733K | Hold |
21,138
| – | – | 0.01% | 1061 |
|
|
2018
Q4 | $413K | Hold |
21,138
| – | – | 0.01% | 1317 |
|
|
2018
Q3 | $563K | Hold |
21,138
| – | – | 0.01% | 1277 |
|
|
2018
Q2 | $798K | Buy |
21,138
+2,823
| +15% | +$108K | 0.01% | 1037 |
|
|
2018
Q1 | $598K | Buy |
18,315
+430
| +2% | +$18.9K | 0.01% | 1162 |
|
|
2017
Q4 | $871K | Sell |
17,885
-19,054
| -52% | -$964K | 0.01% | 967 |
|
|
2017
Q3 | $2M | Buy |
36,939
+2,524
| +7% | +$148K | 0.01% | 939 |
|
|
2017
Q2 | $1.93M | Buy |
34,415
+390
| +1% | +$15.6K | 0.01% | 959 |
|
|
2017
Q1 | $1.33M | Sell |
34,025
-1,273
| -4% | -$40.5K | 0.01% | 1103 |
|
|
2016
Q4 | $792K | Hold |
35,298
| – | – | 0.01% | 1426 |
|
|
2016
Q3 | $802K | Hold |
35,298
| – | – | 0.01% | 1410 |
|
|
2016
Q2 | $833K | Hold |
35,298
| – | – | 0.01% | 1361 |
|
|
2016
Q1 | $720K | Buy |
35,298
+354
| +1% | +$11.2K | 0.01% | 1354 |
|
|
2015
Q4 | $1.8M | Buy |
34,944
+1,626
| +5% | +$78.8K | 0.01% | 933 |
|
|
2015
Q3 | $1.42M | Sell |
33,318
-330
| -1% | -$15.9K | 0.01% | 1033 |
|
|
2015
Q2 | $1.53M | Sell |
33,648
-1,713
| -5% | -$68.9K | 0.01% | 1067 |
|
|
2015
Q1 | $1.34M | Buy |
35,361
+2,092
| +6% | +$71.9K | 0.01% | 1050 |
|
|
2014
Q4 | $942K | Buy |
33,269
+4,570
| +16% | +$127K | 0.01% | 1353 |
|
|
2014
Q3 | $726K | Hold |
28,699
| – | – | 0.01% | 1474 |
|
|
2014
Q2 | $837K | Buy |
28,699
+17,905
| +166% | +$433K | 0.01% | 1476 |
|
|
2014
Q1 | $280K | Hold |
10,794
| – | – | ﹤0.01% | 2237 |
|
|
2013
Q4 | $278K | Buy |
10,794
+198
| +2% | +$4.81K | ﹤0.01% | 2237 |
|
|
2013
Q3 | $283K | Sell |
10,596
-370
| -3% | -$8.8K | ﹤0.01% | 2151 |
|
|
2013
Q2 | $269K | Buy |
+10,966
| New | +$218K | ﹤0.01% | 2130 |
|
Metropolitan Life Insurance Company (MetLife)'s PTLA Position: Q3 2020 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 23,656 shares — an estimated $426K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in PTLA in Q2 2013 and held it in 29 quarters. The position peaked at $2M in Q3 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 23,656 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $426K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 29 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Portola Pharmaceuticals, Inc. position peaked at $2M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2020, filed 13 Nov 2020.